Regeneron and Avalanche Biotechnologies Announce Collaboration to Develop Next-Generation Gene Therapy Products in Ophthalmology

[PR Newswire] – TARRYTOWN, N.Y. and MENLO PARK, Calif., May 5, 2014 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) and Avalanche Biotechnologies, Inc., today announced the formation of a broad collaboration … more

View todays social media effects on REGN

View the latest stocks trending across Twitter. Click to view dashboard

See who Regeneron is hiring next, click here to view